INS and neonatal diabetes mellitus: The identification of a KATP channel mutation can have an impact on the medical management of patients with NDM as approximately 90% can transfer from insulin injections to high‐dose sulphonylurea tablets (Pearson et al., 2006; Zung, Glaser, Nimri, & Zadik, 2004).